Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells

類似資料

• Genetic modification of human T lymphocytes for the treatment of hematologic malignancies
  著者:: Hoyos, Valentina, 等
  出版事項: (2012)
• Fifteen Years of Gene Therapy Based on Chimeric Antigen Receptors: “Are We Nearly There Yet?”
  著者:: Dotti, Gianpietro, 等
  出版事項: (2009)
• Response: To force the expression of CCR4 and/or of CCR5 chemokine receptor in T cells for immunotherapy of Hodgkin lymphoma: that is the question
  著者:: Dotti, Gianpietro, 等
  出版事項: (2010)
• Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
  著者:: Hoyos, Valentina, 等
  出版事項: (2010)
• T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivo
  著者:: Geldres, Claudia, 等
  出版事項: (2013)